Jushi HoldingsJUSHF +4.47%47 PS Ratio is 0.34 as of Jul. 04, 2026, which is 39% below its 10-year median of 0.56. GuruFocus rates JUSHF with a GF Score™ of 47/100 and a GF Value™ of $0.50 (Fairly Valued). The stock has 5 warning signs investors should review. Among 950 Drug Manufacturers companies, Jushi Holdings ranks better than 92.21% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Jushi Holdings's share price is $0.4649.
Jushi Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $1.35. Hence, Jushi Holdings's PS Ratio for today is 0.34.
The historical rank and industry rank for Jushi Holdings's PS Ratio or its related term are showing as below:
JUSHF'
s PS Ratio Range Over the Past 10 Years
Min: 0.2 Med: 0.56 Max: 39.79
Current: 0.32
During the past 13 years, Jushi Holdings's highest PS Ratio was 39.79. The lowest was 0.20. And the median was 0.56.
JUSHF's PS Ratio is ranked better than 92.21% of 950
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs JUSHF: 0.32
Jushi Holdings Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Jushi Holdings was 1.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -0.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.30% per year.
During the past 13 years, Jushi Holdings's highest 3-Year average Revenue per Share Growth Rate was 24.80% per year. The lowest was -0.60% per year. And the median was 12.30% per year.
Back to Basics: PS Ratio
Jushi Holdings (OTCPK:JUSHF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Jushi Holdings PS Ratio Related Terms
Jushi Holdings PS Ratio Historical Data
* Premium members only.
The historical data trend for Jushi Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Jushi Holdings's Share Price of today is $0.4649. Jushi Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.35.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Jushi Holdings (JUSHF) has a PS Ratio of 0.34 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Jushi Holdings and its competitors. This is 39% below median its historical median of 0.56. Over the past decade, Jushi Holdings' PS Ratio has ranged from 0.20 to 39.79. According to the industry distribution chart, Jushi Holdings ranks #74 out of 950 companies in the Drug Manufacturers industry, placing it in the top 7.8%.
Is Jushi Holdings' PS Ratio too high?
Jushi Holdings' current PS Ratio of 0.34 is 39% below median its 10-year median of 0.56. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 39.79. The Drug Manufacturers industry median PS Ratio is 2.32. Jushi Holdings' value of 0.34 is 85.3% below this industry median. Based on the distribution chart, Jushi Holdings ranks #74 out of 950 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jushi Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #74 out of 950 companies for PS Ratio. This places Jushi Holdings in the top 8% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.32. Jushi Holdings' value of 0.34 is 85.3% below this benchmark. Historically, Jushi Holdings' own PS Ratio has ranged from 0.20 to 39.79 over the past decade. While the company's 10-year median is 0.56 vs. the industry median of 2.32, Jushi Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current PS Ratio of 0.34 is 85.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Jushi Holdings and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current PS Ratio is 0.34, which is 39% below median its own 10-year median of 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.50, compared to a current price of $0.46 — trading 7% below its estimated fair value. The current PS Ratio is 0.34, which is 39% below median its 10-year median of 0.56 and 85.3% below the Drug Manufacturers industry median of 2.32. Jushi Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Jushi Holdings (JUSHF), the current PS Ratio is 0.34 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSHF) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.46 is trading 7% below its estimated GF Value™ of $0.50.
GuruFocus considers Jushi Holdings to be Fairly Valued.
Key valuation signals for JUSHF:
PS Ratio: 0.34 (39% below median its 10-year median of 0.56)
GF Value™: $0.50 vs. price of $0.46 (7% below fair value)
Industry Position: 85.3% below the Drug Manufacturers median (#74 of 950)
No single metric tells the full story. See the JUSHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
47GF Score
Get the complete analysis for JUSHF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSHF has been successfully added to your 
